Jim Utts, Chairman Jim Utts is an Operating Partner with Roundtable Healthcare Partners located in Lake Forest, IL (www.roundtablehp.com) having joined the firm in 2007. Prior to this, Jim spent 25 plus years in various senior management roles working for Baxter Healthcare where his most recent position was President of Baxter Europe. He has extensive operating experience in intravenous solutions, drug delivery and infusion therapy businesses worldwide. Mark McWilliams, Chief Executive Officer Mark McWilliams served as Director of Cell Imaging and Analysis at Beckman Coulter after the recent sale of Q3DM to Beckman in December 2003. Mark was President and Chief Executive Officer and Director of Q3DM, a life-sciences startup that raised several angel and venture capital funding rounds. Previously, Mark was founder and COO of Medication Delivery Devices (MDD), an alternate care infusion systems company that was acquired by Baxter Healthcare in 1996. Mr. McWilliams served as a VP of Research and Development at Baxter Healthcare for three years following the sale of MDD. Prior to MDD, Mark served as Product Development Manager at the founding of Block Medical where he was responsible for bringing the company’s first two FDA approved products rapidly to market. Block was sold to Hillenbrand Industries in 1991. Mark previously worked for Hughes Aircraft, Vacuum General and Martin Marietta. He earned his MSME from the Massachusetts Institute of Technology, his BSME from Northeastern University and holds eight utility patents. Harry George Harry George has over 35 years experience in founding, operating and investing in successful rapid growth technology-related companies. He is a co-founder of Solstice Capital. From 1981 to 1989, Mr. George was co-founder, Director, and Vice-President of Finance for Interleaf Inc. During this time Interleaf grew to be a publicly traded company with $100 million in annual revenue . In January 2000, Interleaf was acquired by Broadvision in a stock merger that valued Interleaf at approximately $900 million. Harry has been a Director of a number of private and public companies and is a member of the Investors' Circle. Harry is a member of the advisory committee of the MBA program at the Eller School of Business of the University of Arizona He received an AB from Bowdoin College. Mark Banister, Founder and Chief Technical Officer Mark Banister is the inventor of the Medipacs pump system and unique polymer actuator materials. He has 5 issued patents and 16 pending patents and has authored several published technical papers on smart polymer materials and devices. Mark has over 30 years of experience in business, product design, polymer chemistry, mechanical engineering, manufacturing and tooling design. Currently the PI on a National Science Foundation STTR Phase II Grant, Mark has been able to leverage over $1M in grant funding into over $3M in angel funding. Arthur C. Pinto, M.D., F.A.C.S Dr. Pinto completed his medical education at St. John’s Medical College in Bangalore, India in 1976. He did a residency in Internal Medicine at Bridgeport Hospital and a Urology Residency at Vanderbilt University Medical Center. He was an Instructor in Urology at Tufts Med School. He has been Chief of Urology at Bridgeport Hospital since January, 2000. His special interests include Benign Prostate Hypertrophy (BPH) and urological oncology. He has presented at numerous regional and national Urology meetings and has published in many journals. He is a member of the American Board of Urology and a member of many urological societies.